Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Sulfonylurea
Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine the safety and efficacy of long-term combination
therapy with alogliptin (Nesina) and sulfonylurea in patients with type 2 diabetes mellitus
who responded inadequately to treatment with sulfonylurea in addition to diet therapy and
exercise therapy.